Synopsis
Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Af 1161
2. Af-1161
3. Af1161
4. Apo Trazodone
5. Apo-trazodone
6. Deprax
7. Desyrel
8. Gen Trazodone
9. Gen-trazodone
10. Molipaxin
11. Novo Trazodone
12. Novo-trazodone
13. Nu Trazodone
14. Nu-trazodone
15. Pms Trazodone
16. Pms-trazodone
17. Ratio Trazodone
18. Ratio-trazodone
19. Ratiotrazodone
20. Thombran
21. Tradozone
22. Trazodon Hexal
23. Trazodon Neuraxpharm
24. Trazodon-neuraxpharm
25. Trazodone
26. Trazodonneuraxpharm
27. Trazon
28. Trittico
1. 25332-39-2
2. Trazodone Hcl
3. Desyrel
4. Bimaran
5. Molipaxin
6. Thombran
7. Trazodone (hydrochloride)
8. Af-1161
9. Trialodine
10. Kb-831
11. Oleptro
12. 19666-36-5
13. 6e8zo8lrnm
14. 2-(3-(4-(3-chlorophenyl)piperazin-1-yl)propyl)-[1,2,4]triazolo[4,3-a]pyridin-3(2h)-one Hydrochloride
15. Nsc-292811
16. Af-1161 (free Base)
17. 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one Hydrochloride
18. 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;hydrochloride
19. Mls000069698
20. Chebi:9655
21. 1,2,4-triazolo[4,3-a]pyridin-3(2h)-one,2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-,hydrochloride (1:1)
22. 2-(3-(4-(m-chlorophenyl)-1-piperazinyl)propyl)-s-triazolo(4,3-a)pyridin-3(2h)-one Monohydrochloride
23. Trazodone Hydrochloride (desyrel)
24. 1,2,4-triazolo(4,3-a)pyridin-3(2h)-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-, Monohydrochloride
25. Devidon
26. Pragmazone
27. Smr000058520
28. Tombran
29. Tritico
30. Triticum
31. Azona
32. 25332-39-2 (hcl)
33. Apo-trazodone
34. Dsstox_cid_24626
35. Dsstox_rid_80361
36. Dsstox_gsid_44626
37. 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2h)-one Hydrochloride
38. Desyrel Dividose
39. 2-(3-(4-(3-chlorophenyl)piperazin-1-yl)propyl)-1,2,4-triazolo(4,3-a)pyridin-3(2h)-one Hydrochloride
40. 2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}-2h,3h-[1,2,4]triazolo[4,3-a]pyridin-3-one Hydrochloride
41. Sr-01000000190
42. Ncgc00016035-02
43. Einecs 246-855-5
44. Unii-6e8zo8lrnm
45. Cas-25332-39-2
46. Nsc 292811
47. Af 1161
48. Trazodone, Hcl
49. 2-[3-[4-(m-chlorophenyl)-1-piperazinyl]propyl]-s-triazolo[4,3-a]pyridin-3(2h)-one Monohydrochloride
50. Prestwick_478
51. Desyrel (tn)
52. Einecs 243-216-2
53. Trazodone Hydrochloride [usan:usp:jan]
54. 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,5-a]pyridin-3-one
55. Opera_id_850
56. Schembl61754
57. 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2h)-one Hydrochloride
58. Mls000758230
59. Mls001148260
60. Mls001424009
61. Spectrum1503121
62. Chembl1200798
63. Dtxsid8044626
64. Hms1568l06
65. Hms1922g09
66. Pharmakon1600-01503121
67. Trazodone Hydrochloride (jan/usp)
68. Bcp04922
69. Hy-b0478
70. Tox21_110286
71. Tox21_302685
72. Tox21_501159
73. Trazodone Hydrochloride [mi]
74. Ccg-40299
75. Nsc292811
76. Nsc758393
77. Trazodone Hydrochloride [jan]
78. Trazodone Hydrochloride [hsdb]
79. Trazodone Hydrochloride [usan]
80. Akos015897762
81. Tox21_110286_1
82. Ac-6779
83. Ks-5100
84. Lp01159
85. Nc00046
86. Nsc-758393
87. Trazodone Hydrochloride [mart.]
88. Trazodone Hydrochloride [vandf]
89. Trazodone Hydrochloride [usp-rs]
90. Trazodone Hydrochloride [who-dd]
91. Trazodone Hydrochloride Impurity Standard
92. Ncgc00016035-13
93. Ncgc00094420-01
94. Ncgc00094420-02
95. Ncgc00094420-03
96. Ncgc00094420-04
97. Ncgc00256807-01
98. Ncgc00261844-01
99. 2-(3-(4-(3-chlorophenyl)piperazin-1-y)propyl)-1,2,4-triazolo(4,3-a)pyridine-3(2h)-one Hydrochloride
100. S-triazolo(4,3-a)pyridin-3(2h)-one, 2-(3-(4-(m-chlorophenyl)-1-piperazinyl)propyl)-, Monohydrochloride
101. Eu-0101159
102. Ft-0659024
103. Ft-0675364
104. S2582
105. Trazodone Hydrochloride [orange Book]
106. D00820
107. D97808
108. T 6154
109. Trazodone Hydrochloride [usp Monograph]
110. Trazodone Hydrochloride, >=99% (hplc), Powder
111. 332t392
112. A813950
113. A817789
114. A924854
115. 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-
116. J-015941
117. Sr-01000000190-2
118. Sr-01000000190-8
119. Wln: T56 Anvnnj C3- At6n Dntj Dr Cg &gh
120. Q27108459
121. 1,2,4-triazolo[4,3-a]pyridin-3(2h)-one Hydrochloride
122. Z1550675462
123. Trazodone Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
124. Trazodone Hydrochloride, United States Pharmacopeia (usp) Reference Standard
125. S-triazolo[4, 2-[3-[4-(m-chlorophenyl)-1-piperazinyl]propyl]-, Monohydrochloride
126. S-trizolo[4, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-, Hydrochloride
127. 1,2,4-triazolo[4,3-a]pyridin-3(2h)-one, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-, Hydrochloride (1:1)
128. 1,4-triazolo[4,3-a]pyridin-3(2h)-one, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-, Monohydrochloride
129. 2-(3-(4-(3-chlorophenyl)piperazin-1-yl)propyl)-[1,2,4]triazolo[4,3-a]pyridin-3(2h)-onehydrochloride
130. 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one Hydrochloride
131. 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;hydron;chloride
132. 2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2h)-one Hydrochloride
133. Trazodone Hydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
| Molecular Weight | 408.3 g/mol |
|---|---|
| Molecular Formula | C19H23Cl2N5O |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Exact Mass | 407.1279658 g/mol |
| Monoisotopic Mass | 407.1279658 g/mol |
| Topological Polar Surface Area | 42.4 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 611 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 4 | |
|---|---|
| Drug Name | Oleptro |
| PubMed Health | Trazodone (By mouth) |
| Drug Classes | Antidepressant |
| Drug Label | Oleptro (trazodone hydrochloride) is a triazolopyridine. It is a white, odorless crystalline powder which is freely soluble in water.Chemical Name: 2-[3-[4-(m-Chlorophenyl)-1-piperazinyl]propyl]-s-triazolo[4,3-a]pyridin-3(2H)-one monohydrochloride St... |
| Active Ingredient | Trazodone hydrochloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | 150mg; 300mg |
| Market Status | Prescription |
| Company | Angelini Pharma |
| 2 of 4 | |
|---|---|
| Drug Name | Trazodone hydrochloride |
| Drug Label | Trazodone HCl is an antidepressant chemically unrelated to tricyclic, tetracyclic, or other known antidepressant agents. Trazodone HCl is a triazolopyridine derivative designated as 2-[3-[4-(m-Chlorophenyl)-1-piperazinyl]propyl]s-triazolo[4,3-a]-pyri... |
| Active Ingredient | Trazodone hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 150mg; 300mg; 100mg; 50mg |
| Market Status | Prescription |
| Company | Mylan Pharms; Apotex; Teva Pharms Usa; Torrent Pharms; Mutual Pharm; Vintage; Alvogen; Pliva |
| 3 of 4 | |
|---|---|
| Drug Name | Oleptro |
| PubMed Health | Trazodone (By mouth) |
| Drug Classes | Antidepressant |
| Drug Label | Oleptro (trazodone hydrochloride) is a triazolopyridine. It is a white, odorless crystalline powder which is freely soluble in water.Chemical Name: 2-[3-[4-(m-Chlorophenyl)-1-piperazinyl]propyl]-s-triazolo[4,3-a]pyridin-3(2H)-one monohydrochloride St... |
| Active Ingredient | Trazodone hydrochloride |
| Dosage Form | Tablet, extended release |
| Route | Oral |
| Strength | 150mg; 300mg |
| Market Status | Prescription |
| Company | Angelini Pharma |
| 4 of 4 | |
|---|---|
| Drug Name | Trazodone hydrochloride |
| Drug Label | Trazodone HCl is an antidepressant chemically unrelated to tricyclic, tetracyclic, or other known antidepressant agents. Trazodone HCl is a triazolopyridine derivative designated as 2-[3-[4-(m-Chlorophenyl)-1-piperazinyl]propyl]s-triazolo[4,3-a]-pyri... |
| Active Ingredient | Trazodone hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 150mg; 300mg; 100mg; 50mg |
| Market Status | Prescription |
| Company | Mylan Pharms; Apotex; Teva Pharms Usa; Torrent Pharms; Mutual Pharm; Vintage; Alvogen; Pliva |
Treatment of insomnia
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
Antidepressive Agents, Second-Generation
A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)
Selective Serotonin Reuptake Inhibitors
Compounds that specifically inhibit the reuptake of serotonin in the brain. (See all compounds classified as Selective Serotonin Reuptake Inhibitors.)
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-08-22
Pay. Date : 2023-07-17
DMF Number : 37593
Submission : 2022-12-28
Status : Active
Type : II
NDC Package Code : 62207-019
Start Marketing Date : 2023-01-16
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
| Available Reg Filing : ASMF, CN |
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-12-27
Pay. Date : 2012-11-13
DMF Number : 16459
Submission : 2003-03-10
Status : Active
Type : II
JPN Pharma offers excellence in API manufacturing through precision, innovation & quality, delivering solutions to the pharma industry
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7459
Submission : 1988-05-05
Status : Inactive
Type : II
Date of Issue : 2025-06-04
Valid Till : 2028-05-20
Written Confirmation Number : WC-0001
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-02-12
Pay. Date : 2012-12-24
DMF Number : 20920
Submission : 2007-10-04
Status : Active
Type : II
Certificate Number : CEP 2022-166 - Rev 02
Issue Date : 2025-01-29
Type : Chemical
Substance Number : 2857
Status : Valid
Date of Issue : 2025-06-30
Valid Till : 2028-07-02
Written Confirmation Number : WC-0123
Address of the Firm :
NDC Package Code : 65085-0014
Start Marketing Date : 1999-06-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : Reviewed
Rev. Date : 2013-10-04
Pay. Date : 2013-09-26
DMF Number : 6721
Submission : 1986-12-01
Status : Active
Type : II
Registration Number : 222MF10059
Registrant's Address : NUERNBERGER STRASSE 12, 90537 FEUCHT, GERMANY
Initial Date of Registration : 2010-02-17
Latest Date of Registration :
NDC Package Code : 24823-911
Start Marketing Date : 2013-04-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16207
Submission : 2002-10-25
Status : Inactive
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Desyrel-Generic (trazodone hydrochloride) is a selective serotonin reuptake inhibitor indicated for the treatment of patients with major depressive disorder.
Lead Product(s): Trazodone Hydrochloride,Inapplicable
Therapeutic Area: Psychiatry/Psychology Brand Name: Desyrel-Generic
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable August 09, 2024
Lead Product(s) : Trazodone Hydrochloride,Inapplicable
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Granules India Gains ANDA approval for Trazodone Tablets
Details : Desyrel-Generic (trazodone hydrochloride) is a selective serotonin reuptake inhibitor indicated for the treatment of patients with major depressive disorder.
Product Name : Desyrel-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 09, 2024
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Trazodone HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Lead Product(s): Trazodone Hydrochloride,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: SocraTec R&D GmbH
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 14, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Trazodone Hydrochloride,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : SocraTec R&D GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioavailability of Trazodone Hydrochloride (New Polymer) Vs. Trazodone Hydrochloride Contramid®...
Details : Trazodone HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 14, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
AD504 (Atomoxetine) showed a significant reduction of the Apnea Hypopnea Index (AHI) (from 18.2 [11.8 to 31.3] on placebo to 7.4 [5.4 to 16.1] events/h on AD504, p=0.024 and Hypoxic Burden (HB) from 46.3 [25.1 to 88.3] on placebo to 18.7 [14.9 to 43.5], p=0.003 on AD504.
Lead Product(s): Atomoxetin Hydrochloride,Trazodone Hydrochloride
Therapeutic Area: Sleep Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable June 02, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Atomoxetin Hydrochloride,Trazodone Hydrochloride
Therapeutic Area : Sleep
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : AD504 (Atomoxetine) showed a significant reduction of the Apnea Hypopnea Index (AHI) (from 18.2 [11.8 to 31.3] on placebo to 7.4 [5.4 to 16.1] events/h on AD504, p=0.024 and Hypoxic Burden (HB) from 46.3 [25.1 to 88.3] on placebo to 18.7 [14.9 to 43.5], ...
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 02, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Trazodone HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Lead Product(s): Trazodone Hydrochloride,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Cross Research S.A.
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable November 29, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Trazodone Hydrochloride,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Cross Research S.A.
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Trazodone HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 29, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
AD504 (atomoxetine plus trazodone) showed a strong trend in the reduction in apnea hypopnea index (AHI) from placebo, which was the study’s primary endpoint.
Lead Product(s): Atomoxetin Hydrochloride,Trazodone Hydrochloride
Therapeutic Area: Sleep Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable November 16, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Atomoxetin Hydrochloride,Trazodone Hydrochloride
Therapeutic Area : Sleep
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : AD504 (atomoxetine plus trazodone) showed a strong trend in the reduction in apnea hypopnea index (AHI) from placebo, which was the study’s primary endpoint.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 16, 2021

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Trazodone Hydrochlorid...
Dosage Form : Immediate Release Tabl...
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info :
Dosage : Immediate Release Tabl...
Dosage Strength : 50MG
Brand Name : Trazodone Hydrochlorid...
Approval Date :
Application Number :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Trazodone Hydrochlorid...
Dosage Form : Immediate Release Tabl...
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info :
Dosage : Immediate Release Tabl...
Dosage Strength : 100MG
Brand Name : Trazodone Hydrochlorid...
Approval Date :
Application Number :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Trazodone Hydrochlorid...
Dosage Form : Immediate Release Tabl...
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info :
Dosage : Immediate Release Tabl...
Dosage Strength : 150MG
Brand Name : Trazodone Hydrochlorid...
Approval Date :
Application Number :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Trazodone Hydrochlorid...
Dosage Form : Immediate Release Tabl...
Dosage Strength : 300MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info :
Dosage : Immediate Release Tabl...
Dosage Strength : 300MG
Brand Name : Trazodone Hydrochlorid...
Approval Date :
Application Number :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : ROW
Registration Country : India
Brand Name : Trazodone
Dosage Form : Tablet
Dosage Strength : 34.88%
Packaging :
Approval Date :
Application Number :
Regulatory Info : ROW
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Packaging :
Regulatory Info : ROW
Dosage : Tablet
Dosage Strength : 34.88%
Brand Name : Trazodone
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : France
Brand Name : Trazodone Hydrochlorid...
Dosage Form : Sustained Release Tabl...
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Packaging :
Regulatory Info :
Dosage : Sustained Release Tabl...
Dosage Strength : 150MG
Brand Name : Trazodone Hydrochlorid...
Approval Date :
Application Number :
Registration Country : France
Regulatory Info :
Registration Country : France
Brand Name : Trazodone Hydrochlorid...
Dosage Form : Sustained Release Tabl...
Dosage Strength : 300MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Packaging :
Regulatory Info :
Dosage : Sustained Release Tabl...
Dosage Strength : 300MG
Brand Name : Trazodone Hydrochlorid...
Approval Date :
Application Number :
Registration Country : France
Regulatory Info :
Registration Country : India
Brand Name : Trazodone Hydrochlorid...
Dosage Form : Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 50MG
Brand Name : Trazodone Hydrochlorid...
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Trazodone Hydrochlorid...
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 100MG
Brand Name : Trazodone Hydrochlorid...
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Trazodone Hydrochlorid...
Dosage Form : Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 150MG
Brand Name : Trazodone Hydrochlorid...
Approval Date :
Application Number :
Registration Country : India
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Application : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Excipient Details : CS90 is a directly compressible calcium carbonate with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-175 µm, Tapped Density: 0.85
Ingredient(s) : Calcium Carbonate Excipient
Application : Fillers, Diluents & Binders
Excipient Details : KoVidone® K25 is used as a low viscosity wet binder in solid dosage forms such as capsules and tablets.
Brand Name : Lactose Monohydrate
Application : Parenteral
Excipient Details : Lactose monohydrate is used as a diluent in inhalation and lyophilized preparations.
Grade : Oral
Category : Co-Processed Excipients, Fillers, Diluents & Binders
Application : Co-Processed Excipients, Fillers, Diluents & Binders
Excipient Details : ProBlend (SMCC) is a co-processed excipient consists of microcrystalline cellulose & colloidal silicon dioxide, used as a diluent & binder in OSDs.
Pharmacopoeia Ref : USP-NF, DMF, EXCiPAT, KOSHER, ...
Technical Specs : NA
Ingredient(s) : Microcrystalline Cellulose Excipients
Application : Co-Processed Excipients, Fillers, Diluents & Binders
Excipient Details : Microlose (Lactose Monohydrate & Microcrystalline Cellulose) is used as a diluent in oral dosage forms such as tablets.
Pharmacopoeia Ref : DMF, EXCiPAT, KOSHER, HALAL, W...
Technical Specs : Lactose Monohydrate – 40%, Microcrystalline cellulose – 60%
Ingredient(s) : Lactose Monohydrate
Dosage Form : Capsule, Injectable / Parenteral, Tablet
Grade : Oral, Parenteral
Category : Fillers, Diluents & Binders, Parenteral
Grade : Oral
Category : Fillers, Diluents & Binders, Lubricants & Glidants
Application : Fillers, Diluents & Binders, Lubricants & Glidants
Excipient Details : Most popular excipient for the production of tablets and capsules. Offering an efficient and low dosage in capsules.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF
Technical Specs : Specific Surface Area-6-10 m2/g; Particle Size-7-11 µm
Ingredient(s) : Magnesium Stearate
Dosage Form : Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Co-Processed Excipients, Direct Compression, Taste Masking
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Taste Masking
Application : Chewable & Orodispersible Aids, Direct Compression, Taste Masking
Excipient Details : MS90 is a directly compressible magnesium hydroxide with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-170 µm, Tapped Density: 0.80
Ingredient(s) : Magnesium Hydroxide Excipient
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Application : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Excipient Details : CS90 is a directly compressible calcium carbonate with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-175 µm, Tapped Density: 0.85
Ingredient(s) : Calcium Carbonate Excipient
Dosage Form : Tablet
Grade : Oral
Category : Direct Compression, Fillers, Diluents & Binders, Granulation
Application : Direct Compression, Fillers, Diluents & Binders, Granulation
Excipient Details : AceCel is suitable for majority of the directly compressible actives, combines good flow and high compressibility.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Application : Direct Compression
Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...
Technical Specs : Density- Tapped density- 440 g/l, Bulk density- 310 g/l; Particl...
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Capsule, Tablet, Topical Film, Transdermal Patch
Grade : Not Available
Category : Controlled & Modified Release, Direct Compression, Granulation
Application : Controlled & Modified Release, Direct Compression, Granulation
Excipient Details : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 %...
Technical Specs : Not Available
Ingredient(s) : Lauryl Sulfate
Dosage Form : Tablet
Grade : Oral
Category : Direct Compression, Fillers, Diluents & Binders, Granulation
Application : Direct Compression, Fillers, Diluents & Binders, Granulation
Excipient Details : HiCel acts as a strong dry binder. It facilitates low tablet friability & promotes rapid tablet disintegration.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Brand Name : Sheffield™ Spray Dried 316 Fast Flo®
Application : Direct Compression
Excipient Details : Pharmaceutical excipient used in direct compression
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Lactose Monohydrate
Application : Direct Compression
Pharmacopoeia Ref : Conforms to Ph. Eur., Lactose ...
Technical Specs : Density- Tapped density- 906 g/l, Bulk density- 722 g/l; Particle...
Ingredient(s) : Anhydrous Lactose
Brand Name : Sheffield™ Spray Dried 315
Application : Direct Compression
Excipient Details : Pharmaceutical excipient used in direct compression
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Lactose Monohydrate
Dosage Form : Tablet
Grade : Oral
Category : Granulation, Lubricants & Glidants, Surfactant & Foaming Agents
Grade : Oral
Category : Fillers, Diluents & Binders, Lubricants & Glidants
Application : Fillers, Diluents & Binders, Lubricants & Glidants
Excipient Details : Most popular excipient for the production of tablets and capsules. Offering an efficient and low dosage in capsules.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF
Technical Specs : Specific Surface Area-6-10 m2/g; Particle Size-7-11 µm
Ingredient(s) : Magnesium Stearate
Application : Lubricants & Glidants
Excipient Details : TABLUBE is one of the oldest and most widely used lubricants for tablet, capsules and other solid dosage forms.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Magnesium Stearate
Brand Name : Magnesium Stearate
Application : Lubricants & Glidants
Excipient Details : Magnesium stearate is the magnesium salt of stearic acid. It acts as a lubricating agent in tablet manufacturing.
Pharmacopoeia Ref : USP/BP/EP/PH.EUR
Technical Specs : Not Available
Ingredient(s) : Magnesium Stearate
Grade : Oral
Category : Disintegrants & Superdisintegrants, Granulation, Lubricants & Glidants
Application : Disintegrants & Superdisintegrants, Granulation, Lubricants & Glidants
Grade : Oral
Category : Fillers, Diluents & Binders, Lubricants & Glidants
Application : Fillers, Diluents & Binders, Lubricants & Glidants
Excipient Details : Higher specific surface area and a smaller median particle size. This product is preferred for more critical and very fine herbal formulations.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF
Technical Specs : Specific Surface Area-8-12 m2/g; Particle Size-5-9 µm
Ingredient(s) : Magnesium Stearate
Brand Name : Magnesium Stearate
Application : Lubricants & Glidants
Excipient Details : Lubricants, Anti-adhesive, Glidant
Grade : Oral
Category : Fillers, Diluents & Binders, Lubricants & Glidants
Application : Fillers, Diluents & Binders, Lubricants & Glidants
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF
Technical Specs : Specific Surface Area-6-8 m2/g; Particle Size-7-11 µm
Ingredient(s) : Magnesium Stearate
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
38
PharmaCompass offers a list of Trazodone Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Trazodone Hydrochloride manufacturer or Trazodone Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Trazodone Hydrochloride manufacturer or Trazodone Hydrochloride supplier.
PharmaCompass also assists you with knowing the Trazodone Hydrochloride API Price utilized in the formulation of products. Trazodone Hydrochloride API Price is not always fixed or binding as the Trazodone Hydrochloride Price is obtained through a variety of data sources. The Trazodone Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tritico manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tritico, including repackagers and relabelers. The FDA regulates Tritico manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tritico API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tritico manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tritico supplier is an individual or a company that provides Tritico active pharmaceutical ingredient (API) or Tritico finished formulations upon request. The Tritico suppliers may include Tritico API manufacturers, exporters, distributors and traders.
click here to find a list of Tritico suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tritico DMF (Drug Master File) is a document detailing the whole manufacturing process of Tritico active pharmaceutical ingredient (API) in detail. Different forms of Tritico DMFs exist exist since differing nations have different regulations, such as Tritico USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tritico DMF submitted to regulatory agencies in the US is known as a USDMF. Tritico USDMF includes data on Tritico's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tritico USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tritico suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tritico Drug Master File in Japan (Tritico JDMF) empowers Tritico API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tritico JDMF during the approval evaluation for pharmaceutical products. At the time of Tritico JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tritico suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Tritico Drug Master File in Korea (Tritico KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Tritico. The MFDS reviews the Tritico KDMF as part of the drug registration process and uses the information provided in the Tritico KDMF to evaluate the safety and efficacy of the drug.
After submitting a Tritico KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Tritico API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Tritico suppliers with KDMF on PharmaCompass.
A Tritico CEP of the European Pharmacopoeia monograph is often referred to as a Tritico Certificate of Suitability (COS). The purpose of a Tritico CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Tritico EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Tritico to their clients by showing that a Tritico CEP has been issued for it. The manufacturer submits a Tritico CEP (COS) as part of the market authorization procedure, and it takes on the role of a Tritico CEP holder for the record. Additionally, the data presented in the Tritico CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Tritico DMF.
A Tritico CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Tritico CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Tritico suppliers with CEP (COS) on PharmaCompass.
A Tritico written confirmation (Tritico WC) is an official document issued by a regulatory agency to a Tritico manufacturer, verifying that the manufacturing facility of a Tritico active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Tritico APIs or Tritico finished pharmaceutical products to another nation, regulatory agencies frequently require a Tritico WC (written confirmation) as part of the regulatory process.
click here to find a list of Tritico suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tritico as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tritico API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tritico as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tritico and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tritico NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tritico suppliers with NDC on PharmaCompass.
Tritico Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tritico GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tritico GMP manufacturer or Tritico GMP API supplier for your needs.
A Tritico CoA (Certificate of Analysis) is a formal document that attests to Tritico's compliance with Tritico specifications and serves as a tool for batch-level quality control.
Tritico CoA mostly includes findings from lab analyses of a specific batch. For each Tritico CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tritico may be tested according to a variety of international standards, such as European Pharmacopoeia (Tritico EP), Tritico JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tritico USP).